EARL CHRISTOPHER 4
4 · REPLIDYNE INC · Filed Jun 30, 2006
Insider Transaction Report
Form 4
REPLIDYNE INCRDYN
EARL CHRISTOPHER
Director
Transactions
- Award
Stock Option (Right to Buy)
2006-06-28+16,313→ 16,313 totalExercise: $10.00Exp: 2016-06-28→ Common Stock (16,313 underlying)
Footnotes (2)
- [F1]The option is immediately exercisable and vests over a three year period with one third vesting on June 28, 2007 (one year after the date of grant) and the remaining two-thirds vesting monthly in equal installments over the next twenty-four months.
- [F2]These options are held for the benefit of an entity controlled by affiliates of Perseus-Soros BioPharmaceutical Fund, LP, of which Mr. Earl is a senior advisor.